83_FR_30308 83 FR 30184 - Center for Scientific Review; Notice of Closed Meeting

83 FR 30184 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 124 (June 27, 2018)

Page Range30184-30185
FR Document2018-13842

Federal Register, Volume 83 Issue 124 (Wednesday, June 27, 2018) 
[Federal Register Volume 83, Number 124 (Wednesday, June 27, 2018)]
[Notices]
[Pages 30184-30185]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-13842]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR18-411: Understanding HIV Viral Suppression and 
Transmission in the United States.
    Date: July 6, 2018.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jose H Guerrier, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 
20892, 301-435-1137, guerriej@csr.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing

[[Page 30185]]

limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 22, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-13842 Filed 6-26-18; 8:45 am]
 BILLING CODE 4140-01-P

30184 Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices Complementary and Integrative Health, NIH, Agenda: To review and evaluate Name of Committee: National Institute of National Institutes of Health, 6707 cooperative agreement applications. Allergy and Infectious Diseases Special Democracy Blvd., Ste. 401, Bethesda, MD Place: National Institutes of Health, Emphasis Panel, AIDSRRC Independent SEP. 20892–5475, (301) 594–3462, khalsap@ Neuroscience Center, 6001 Executive Date: July 17, 2018. mail.nih.gov. Boulevard, Rockville, MD 20852 (Telephone Time: 10:00 a.m. to 12:00 p.m. Information is also available on the Conference Call). Agenda: To review and evaluate grant Institute’s/Center’s home page: https:// Contact Person: Julia Berzhanskaya, Ph.D., applications. nccih.nih.gov/about/naccih/, where an Scientific Review Officer, Office of Place: National Institutes of Health, 5601 agenda and any additional information for Extramural Policy and Review, Division of Fishers Lane, Rockville, MD 20892 the meeting will be posted when available. Extramural Research, National Institute on (Telephone Conference Call). Drug Abuse, NIH, DHHS, 6001 Executive Contact Person: Audrey O. Lau, Ph.D., (Catalogue of Federal Domestic Assistance MPH, Scientific Review Officer, AIDS Program Nos. 93.213, Research and Training Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301–827–5840, Review Branch SRP, Rm. 3E70, National in Complementary and Integrative Health, Institutes of Health, NIAID, 5601 Fishers National Institutes of Health, HHS). julia.berzhanskaya@nih.gov. Lane, MSC 9834, Rockville, MD 20852–9834, (Catalogue of Federal Domestic Assistance 240–669–2081, audrey.lau@nih.gov. Dated: June 21, 2018. Program Nos.: 93.279, Drug Abuse and Michelle D. Trout, Addiction Research Programs, National (Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory Institutes of Health, HHS) Program Nos. 93.855, Allergy, Immunology, Committee Policy. and Transplantation Research; 93.856, Dated: June 21, 2018. Microbiology and Infectious Diseases [FR Doc. 2018–13786 Filed 6–26–18; 8:45 am] Natasha M. Copeland, Research, National Institutes of Health, HHS) BILLING CODE 4140–01–P Program Analyst, Office of Federal Advisory Dated: June 21, 2018. Committee Policy. Natasha M. Copeland, DEPARTMENT OF HEALTH AND [FR Doc. 2018–13789 Filed 6–26–18; 8:45 am] Program Analyst, Office of Federal Advisory HUMAN SERVICES BILLING CODE 4140–01–P Committee Policy. [FR Doc. 2018–13787 Filed 6–26–18; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND National Institute on Drug Abuse; HUMAN SERVICES Notice of Closed Meetings DEPARTMENT OF HEALTH AND National Institutes of Health HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as National Institute of Allergy and National Institutes of Health amended, notice is hereby given of the Infectious Diseases; Notice of Closed following meetings. Meetings Center for Scientific Review; Notice of The meetings will be closed to the Closed Meeting public in accordance with the Pursuant to section 10(d) of the provisions set forth in sections Federal Advisory Committee Act, as Pursuant to section 10(d) of the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., amended, notice is hereby given of the Federal Advisory Committee Act, as as amended. The grant applications and following meetings. amended, notice is hereby given of the the discussions could disclose following meeting. The meetings will be closed to the The meeting will be closed to the confidential trade secrets or commercial public in accordance with the property such as patentable material, public in accordance with the provisions set forth in sections provisions set forth in sections and personal information concerning 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., individuals associated with the grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and as amended. The grant applications and applications, the disclosure of which the discussions could disclose would constitute a clearly unwarranted the discussions could disclose confidential trade secrets or commercial confidential trade secrets or commercial invasion of personal privacy. property such as patentable material, property such as patentable material, Name of Committee: National Institute on and personal information concerning and personal information concerning Drug Abuse Special Emphasis Panel; R13 individuals associated with the grant individuals associated with the grant Conference Grant Review. applications, the disclosure of which Date: July 19, 2018. applications, the disclosure of which Time: 8:00 a.m. to 10:00 p.m. would constitute a clearly unwarranted would constitute a clearly unwarranted Agenda: To review and evaluate grant invasion of personal privacy. invasion of personal privacy. applications. Name of Committee: National Institute of Name of Committee: Center for Scientific Place: National Institutes of Health, Allergy and Infectious Diseases Special Review Special Emphasis Panel; PAR18–411: Neuroscience Center, 6001 Executive Emphasis Panel, HIV Vaccine Research and Understanding HIV Viral Suppression and Boulevard, Rockville, MD 20852 (Virtual Design (HIVRAD) Program (P01 Clinical Trial Transmission in the United States. Meeting). Not Allowed). Date: July 6, 2018. Contact Person: Susan O. McGuire, Ph.D., Date: July 16–17, 2018. Time: 12:00 p.m. to 4:00 p.m. Scientific Review Officer, Office of Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant Extramural Policy and Review, National Agenda: To review and evaluate grant applications. Institute on Drug Abuse, National Institutes applications. Place: National Institutes of Health, 6701 of Health, DHHS, 6001 Executive Blvd., Place: National Institutes of Health, 5601 Rockledge Drive, Bethesda, MD 20892 Room 4245, Rockville, MD 20852, (301) 827– Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). daltland on DSKBBV9HB2PROD with NOTICES 5817, mcguireso@mail.nih.gov. (Telephone Conference Call). Contact Person: Jose H Guerrier, Ph.D., Name of Committee: National Institute on Contact Person: Jay R. Radke, Ph.D., Scientific Review Officer, Center for Drug Abuse Special Emphasis Panel; Scientific Review Officer Scientific Review Scientific Review, National Institutes of Evaluating the NIDA Standardized Research Program, Division of Extramural Activities, Health, 6701 Rockledge Drive, Room 5218, E-Cigarette in Risk Reduction and Related Room #3G11B, National Institutes of Health, MSC 7852, Bethesda, MD 20892, 301–435– Studies (U01). NIAID, 5601 Fishers Lane, MSC–9823, 1137, guerriej@csr.nih.gov. Date: July 20, 2018. Bethesda, MD 20892–9823, (240) 669–5046, This notice is being published less than 15 Time: 11:00 a.m. to 2:00 p.m. jay.radke@nih.gov. days prior to the meeting due to the timing VerDate Sep<11>2014 16:58 Jun 26, 2018 Jkt 244001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1

Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices 30185 limitations imposed by the review and Contact Person: Sudha Veeraraghavan, Centers of Research Excellence (SCORE) on funding cycle. Ph.D., Scientific Review Officer, Center for Sex Differences. (Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of Date: July 24–26, 2018. Program Nos. 93.306, Comparative Medicine; Health, 6701 Rockledge Drive, Bethesda, MD Time: 10:00 a.m. to 6:00 p.m. 93.333, Clinical Research, 93.306, 93.333, 20892, 301–435–1504, Agenda: To review and evaluate grant 93.337, 93.393–93.396, 93.837–93.844, sudha.veeraraghavan@nih.gov. applications. 93.846–93.878, 93.892, 93.893, National Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 Institutes of Health, HHS) Review Special Emphasis Panel; PAR Panel: Rockledge Drive, Bethesda, MD 20892. Multidisciplinary Studies of HIV/AIDS and Contact Person: Elaine Sierra-Rivera, Ph.D., Dated: June 22, 2018. Scientific Review Officer, EMNR IRG, Center Aging. Natasha M. Copeland, Date: July 20, 2018. for Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory Time: 10:00 a.m. to 4:00 p.m. Health, 6701 Rockledge Drive, Room 6182, Committee Policy. Agenda: To review and evaluate grant MSC 7892, Bethesda, MD 20892, 301 435– applications. 2514, riverase@csr.nih.gov. [FR Doc. 2018–13842 Filed 6–26–18; 8:45 am] Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific BILLING CODE 4140–01–P Review Special Emphasis Panel; Nephrology Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Small Business Review. Contact Person: Barna Dey, Ph.D., Date: July 25, 2018. DEPARTMENT OF HEALTH AND Scientific Review Officer, Center for Time: 9:00 a.m. to 6:00 p.m. HUMAN SERVICES Scientific Review, National Institutes of Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 3184, applications. National Institutes of Health Bethesda, MD 20892, 301–451–2796, bdey@ Place: National Institutes of Health, 6701 mail.nih.gov. Rockledge Drive, Bethesda, MD 20892 Center for Scientific Review; Notice of (Virtual Meeting). Name of Committee: Center for Scientific Closed Meetings Contact Person: Atul Sahai, Ph.D., Review Special Emphasis Panel; RFA–DK– Scientific Review Officer, Center for 17–038: HIV-Associated Digestive and Liver Pursuant to section 10(d) of the Scientific Review, National Institutes of Diseases. Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 2188, Date: July 20, 2018. MSC 7818, Bethesda, MD 20892, 301–435– amended, notice is hereby given of the Time: 10:30 a.m. to 5:00 p.m. 1198, sahaia@csr.nih.gov. following meetings. Agenda: To review and evaluate grant applications. Name of Committee: Center for Scientific The meetings will be closed to the Review Special Emphasis Panel; Toxicology Place: National Institutes of Health, 6701 public in accordance with the Rockledge Drive, Bethesda, MD 20892 and Digestive, Kidney and Urological provisions set forth in sections (Telephone Conference Call). Systems AREA Review. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Jingsheng Tuo, Ph.D., Date: July 25, 2018. as amended. The grant applications and Scientific Review Officer, Center for Time: 9:00 a.m. to 6:00 p.m. the discussions could disclose Scientific Review, National Institutes of Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 5207, applications. confidential trade secrets or commercial Bethesda, MD 20892, 301–451–8754, tuoj@ Place: National Institutes of Health, 6701 property such as patentable material, Rockledge Drive, Bethesda, MD 20892 and personal information concerning nei.nih.gov. (Virtual Meeting). individuals associated with the grant Name of Committee: Center for Scientific Contact Person: Aiping Zhao, MD, applications, the disclosure of which Review Special Emphasis Panel; Member Scientific Review Officer, Center for Conflict: Molecular, Cellular and Biophysical Scientific Review, National Institutes of would constitute a clearly unwarranted Neuroscience. Health, 6701 Rockledge Drive, Room 2188, invasion of personal privacy. Date: July 20, 2018. MSC 7818, Bethesda, MD 20892–7818, (301) Name of Committee: Center for Scientific Time: 1:00 p.m. to 5:00 p.m. 435–0682, zhaoa2@csr.nih.gov. Review Special Emphasis Panel; Special: Agenda: To review and evaluate grant Name of Committee: Center for Scientific AIDS and Related Research. applications. Review Special Emphasis Panel; Biological Date: July 6, 2018. Place: National Institutes of Health, 6701 Chemistry and Macromolecular Biophysics Time: 1:30 p.m. to 4:00 p.m. Rockledge Drive, Bethesda, MD 20892 Member Conflict. Agenda: To review and evaluate grant (Telephone Conference Call). Date: July 25, 2018. applications. Contact Person: Christine A. Piggee, Ph.D., Time: 10:00 a.m. to 4:00 p.m. Place: National Institutes of Health, 6701 Scientific Review Officer, Center for Agenda: To review and evaluate grant Rockledge Drive, Bethesda, MD 20892 Scientific Review, National Institutes of applications. (Telephone Conference Call). Health, 6701 Rockledge Drive, Room 4186, Place: National Institutes of Health, 6701 Contact Person: Mark P. Rubert, Ph.D., MSC 7850, Bethesda, MD 20892, 301–435– Rockledge Drive, Bethesda, MD 20892 Scientific Review Officer, Center for 0657, christine.piggee@nih.gov. (Virtual Meeting). Scientific Review, National Institutes of Name of Committee: Center for Scientific Contact Person: Mike Radtke, Ph.D., Health, 6701 Rockledge Drive, Room 5218, Review Special Emphasis Panel; PAR–17– Scientific Review Officer, Center for MSC 7852, Bethesda, MD 20892, 301–435– 316: Biomedical Technology Research Scientific Review, National Institutes of 1775, rubertm@csr.nih.gov. Resource (P41). Health, 6701 Rockledge Drive, Room 4176, This notice is being published less than 15 Date: July 24, 2018. MSC 7806, Bethesda, MD 20892, 301–435– days prior to the meeting due to the timing Time: 10:00 a.m. to 6:00 p.m. 1728, radtkem@csr.nih.gov. limitations imposed by the review and Agenda: To review and evaluate grant Name of Committee: Center for Scientific funding cycle. applications. Review Special Emphasis Panel; Member Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 Conflict: Pharmacology. Review Special Emphasis Panel; Maximizing Rockledge Drive, Bethesda, MD 20892. Date: July 25, 2018. daltland on DSKBBV9HB2PROD with NOTICES Investigators’ Research Award (R35). Contact Person: Joseph Thomas Peterson, Time: 11:00 a.m. to 1:00 p.m. Date: July 19–20, 2018. Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant Time: 8:00 a.m. to 5:00 p.m. Scientific Review, National Institutes of applications. Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 4118, Place: National Institutes of Health, 6701 applications. MSC 7814, Bethesda, MD 20892, 301–408– Rockledge Drive, Bethesda, MD 20892 Place: Embassy Suites at the Chevy Chase 9694, petersonjt@csr.nih.gov. (Telephone Conference Call). Pavilion, 4300 Military Road NW, Name of Committee: Center for Scientific Contact Person: Richard D. Crosland, Washington, DC 20015. Review Special Emphasis Panel; Specialized Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 16:58 Jun 26, 2018 Jkt 244001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1


Document Created: 2018-11-06 09:52:15
Document Modified: 2018-11-06 09:52:15
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 6, 2018.
FR Citation83 FR 30184 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR